FDA Says May Study Hyperactivity Drug Risk (Reuters)


Reuters - The U.S. Food and Drug
Administration has warned that people with heart problems
should not take the hyperactivity drug Adderall, and studies
may be done to see if it raises risk in others, a top official
at the agency said on Thursday.

Read more...